510(k) Report

510(k) · Cleared

Recalled · Class II · 2016

Distaflo Bypass Graft

K983861510(k) AbbreviatedCleared Nov 24, 199822-day reviewClass II21 CFR 870.3450Recalls 2

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Impra, Inc. · DSY Prosthesis, Vascular Graft, Of 6mm And Greater Diameter

Cleared on Nov 24, 1998 after a 22-day review. The FDA summary names its predicate without a number. 7 later devices descend from it. It has been recalled 2 times.

Decided
Nov 24, 1998
Review
22 days
Class
Class II
Product code
DSY
Recalls
2
Predicates
0

7 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 2009: 2 descendants cleared2005: 1 descendant cleared2014: 1 descendant cleared2015: 1 descendant cleared2010: 1 descendant cleared2025: 1 descendant cleared1995200020052010201520202025
  1. This deviceK983861 Distaflo Bypass GraftImpra, Inc. · 1998
  2. Descendant · cites it directly · 5 of its ownK050049 Dynaflo Bypass GraftBard Peripheral Vascular, Inc. · 2005
  3. Descendant · cites it directly · 4 of its ownK083169 Eptfe Slftm Spiral Vascular GraftTayside Flow Technologies Limited · 2009
  4. Descendant · 2 generations on · 1 of its ownK142062 Spiral Flow Peripheral Vascular GraftVascular Flow Technologies, Ltd. · 2014
  5. Descendant · 2 generations on · 1 of its ownK094044 Spiral Laminar Flow Vascular Arteriovenous GraftTayside Flow Technologies Limited · 2010
  6. Descendant · 3 generations on · 0 of its ownK252277 Spiral Laminar Flow™ Vascular Arteriovenous Graft (AV0645)Vascular Flow Technologies Limited · 2025

Showing 5 of 7 descendants. See all descendants

Descendants cleared per year

2005: 12009: 22010: 12014: 12015: 12025: 1
2005high 2 (2009) · low 0 (2006)2026

Most influential descendants

Showing 5 of 7 · See all
  • K050049Dynaflo Bypass GraftBard Peripheral Vascular, Inc. · 2005 · cites it directly5descendants
  • K083169Eptfe Slftm Spiral Vascular GraftTayside Flow Technologies Limited · 2009 · cites it directly4descendants
  • K142062Spiral Flow Peripheral Vascular GraftVascular Flow Technologies, Ltd. · 2014 · 2 generations on1descendant
  • K094044Spiral Laminar Flow Vascular Arteriovenous GraftTayside Flow Technologies Limited · 2010 · 2 generations on1descendant
  • K252277Spiral Laminar Flow™ Vascular Arteriovenous Graft (AV0645)Vascular Flow Technologies Limited · 2025 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K983861Distaflo Bypass GraftImpra, Inc.1998—
+1K050049Dynaflo Bypass GraftBard Peripheral Vascular, Inc.2005—
+1K083169Eptfe Slftm Spiral Vascular GraftTayside Flow Technologies Limited2009—
+2K142062Spiral Flow Peripheral Vascular GraftVascular Flow Technologies, Ltd.2014—
+2K094044Spiral Laminar Flow Vascular Arteriovenous GraftTayside Flow Technologies Limited2010—
+3K252277Spiral Laminar Flow™ Vascular Arteriovenous Graft (AV0645)Vascular Flow Technologies Limited2025—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200510
200920
201010
201410
201510
202510
FIG. 1 — Lineage of K983861, 1998–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DSY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DSY device

  1. #1 K252445 Fusion Bioline Vascular Graftscore 12.4 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—IMPRA Carboflo® Vascular Graft
Named without a submission number
—
*—Venaflo® Vascular Graft
Named without a submission number
—

What descends from it? (7)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K050049Dynaflo Bypass GraftBard Peripheral Vascular, Inc.20055
K083169Eptfe Slftm Spiral Vascular GraftTayside Flow Technologies Limited20094
K091778Vascutek Cobrahood Eptfe Vascular GraftsVascutek, Ltd.20090

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jan 5, 2016Class IIZ-0786-2016Error in labelingSize mislabeling; the graft is a 6 mm diameter graft when the actual packaged product is an 8 mm graft.
Jan 5, 2016Class IIZ-0785-2016Error in labelingSize mislabeling; the graft is labeled as a 6 mm diameter graft when the actual packaged product is an 8 mm graft.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K050049 (Bard Peripheral Vascular, Inc., 2005) has gone furthest, with 5 descendants of its own.

How does its category compare?

All DSY devices

DSY Prosthesis, Vascular Graft, Of 6mm And Greater Diameter: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DSY

2in 2025

2007: 12008: 12009: 52010: 42011: 12012: 42013: 52014: 22015: 12016: 12017: 32018: 12019: 12020: 12021: 22022: 22023: 22024: 52025: 22026 (partial year): 1
2007high 5 (2009) · low 1 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DSY

160in 2024

2009: 73 days median2010: 55 days median2012: 30 days median2013: 69 days median2017: 269 days median2024: 160 days median
2007high 269 (2017) · low 30 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DSY

1in 2025

2009: 22010: 52013: 12016: 22025: 12026 (partial year): 1
2007high 5 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DSY

151in 2025

2007: 1202008: 1642009: 1932010: 1872011: 1652012: 1772013: 2072014: 3522015: 4602016: 2172017: 1932018: 2002019: 2322020: 1692021: 1682022: 1552023: 1492024: 1532025: 151
2007high 460 (2015) · low 120 (2007)2025

MAUDE reports naming product code DSY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—0120
20081—0164
20095732193
20104555187
20111—0165
20124300177
20135691207
20142—0352
20151—0460
20161—2217
201732690193
20181—0200
20191—0232
20201—0169
20212—0168
20222—0155
20232—0149
202451600153
20252—1151
20261—1—

What is it indicated for?

Distaflo™ Bypass Grafts are intended for bypass or reconstruction of peripheral arterial blood vessels.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K983861: Distaflo Bypass Graft.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K983861

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026